Home » Topics » BioWorld Science

BioWorld Science
RSS

Favipiravir shows in vitro and in vivo antiviral activity against henipaviruses

May 24, 2018

Apogenix working towards conditional MAA submission for asunercept in E.U.

May 24, 2018

NIAID initiates phase I study of SeVRSV vaccine

May 24, 2018

European Commission approves Sandoz's infliximab biosimilar Zessly

May 24, 2018

Bicycle Therapeutics expands collaboration with AstraZeneca

May 24, 2018

MIW-815 elicits strong and durable cancer immunity

May 24, 2018

Esperion's third pivotal study of bempedoic acid meets primary endpoint

May 24, 2018

DSMB recommends continuation of phase II study of Xanamem in Alzheimer's disease

May 24, 2018

Clinical results reported for bifunctional short-hairpin RNA for Ewing's sarcoma

May 24, 2018

Targeting TGF-beta-1 prevents pulmonary fibrosis in rats

May 24, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....